Dentium (145720) Q2 2026 earnings summary

Executive summary

• Specializes in dental implants and dental medical devices, with a strong export focus (80% of sales overseas).

• Diversifying into hydrogen fuel cell energy business, leveraging zirconia material expertise.

• Operates 24 consolidated subsidiaries globally, with a robust R&D pipeline and significant investments in digital dentistry and energy.

Financial highlights

• H1 2026 consolidated revenue: KRW 160.7 billion, down from KRW 346.5 billion in FY2025 and KRW 407.8 billion in FY2024.

• H1 2026 operating income: KRW 30.5 billion; net income: KRW 30.9 billion; basic EPS: KRW 3,643.

• Total assets as of June 2026: KRW 986.8 billion; equity: KRW 594.6 billion; liabilities: KRW 392.2 billion.

• Cash and cash equivalents at period end: KRW 62.4 billion.

• Dividend payout for the period: KRW 5.17 billion; cash dividend per share: KRW 600.

Outlook and guidance

• Hydrogen fuel cell business (SOFC) expected to begin sales after 2026, with new production facility in Vietnam.

• Dental segment continues to focus on digital solutions and global expansion, especially in China and emerging markets.